50902 Federal Register / Vol. 86, No. 174 / Monday, September 13, 2021 / Notices 

materials were transferred to the 

Museum the same year. The human 

remains include one fragmentary 

skeleton of an adult female, 35–50 years 

old; one fragmentary skeleton of an 

adult male, 35–50 years old; one 

fragmentary skeleton of an adult 

probable male, 35–50 years old; one 

fragmentary skeleton of an adult of 

indeterminate sex, 20–35 years old; two 

fragmentary skeletons of adults of 

indeterminate sex, each more than 20 

years old; one fragmentary skeleton of 

an adult of indeterminate sex, 35–50 

years old; two fragmentary skeletons of 

adults greater of indeterminate sex, each 

more than 50 years old; and one 

fragmentary set of teeth belonging to an 

adult of indeterminate sex and age. No 

known individuals were identified. 

The 1,103 associated funerary objects 

are: Four Avery Engraved type ceramic 

bowls, one Avery Engraved type 

ceramic bottle, 162 Avery Engraved type 

potsherds, two Emory Punctate type 

ceramic jars with castellated rims, one 

Simms Engraved type ceramic carinated 

bowl, 61 Simms Engraved type ceramic 

potsherds, six decorated ceramic bowls, 

one decorated ceramic jar, one 

decorated ceramic bottle, one decorated 

ceramic vessel with four applique nodes 

with rattles, one decorated ceramic 

vessel with four animal effigies on the 

rim, four undecorated ceramic bowls, 

one undecorated ceramic jar, one 

undecorated ceramic red olla vessel, 

two ceramic rattle fragments, 390 

decorated potsherds, 352 undecorated 

potsherds, three ceramic pipe fragments, 

31 small corner-notched projectile 

points, two Gary type projectile points, 

one chipped stone flake, one fragment of 

fire cracked rock, one stone celt, four 

pigment stones, one unmodified stone, 

two copper covered shell earspools, four 

faunal bone fragments, 17 shell beads, 

one engraved shell gorget, four engraved 

shell fragments, 26 shell fragments, four 

wood fragments, five charred corn cob 

fragments, one seed bead with sediment, 

two soil samples with possible textile 

matting, one charcoal sample from a 

vessel, and one daub fragment. 

While the Clement 1 site (34Mc8) 

includes both historic and prehistoric 

components, all the human remains and 

associated funerary objects listed in this 

notice belong to the prehistoric 

component. Based on an analysis of the 

diagnostic cultural materials from the 

site (chipped and ground stone, 

ceramics, bone tools, and ornaments), as 

well as radiocarbon dates obtained from 

more recent investigations there, the 

prehistoric component of the site dates 

to A.D. 1200–1500. Archeological, oral 

traditional, and post-contact European 

historical information reasonably show 

that a cultural affiliation exists between 

the earlier group connected to the 

human remains and associated funerary 

objects at the Clement I site and the 

present-day Caddo Nation of Oklahoma. 

Determinations Made by the Sam Noble 

Oklahoma Museum of Natural History 

Officials of the Sam Noble Oklahoma 

Museum of Natural History have 

determined that: 

• Pursuant to 25 U.S.C. 3001(9), the 

human remains described in this notice 

represent the physical remains of 10 

individuals of Native American 

ancestry. 

• Pursuant to 25 U.S.C. 3001(3)(A), 

the 1,103 objects described in this 

notice are reasonably believed to have 

been placed with or near individual 

human remains at the time of death or 

later as part of the death rite or 

ceremony. 

• Pursuant to 25 U.S.C. 3001(2), there 

is a relationship of shared group 

identity that can be reasonably traced 

between the Native American human 

remains and associated funerary objects 

and the Caddo Nation of Oklahoma. 

Additional Requestors and Disposition 

Lineal descendants or representatives 

of any Indian Tribe or Native Hawaiian 

organization not identified in this notice 

that wish to request transfer of control 

of these human remains and associated 

funerary objects should submit a written 

request with information in support of 

the request to Dr. Marc Levine, 

Associate Curator of Archaeology, Sam 

Noble Oklahoma Museum of Natural 

History, University of Oklahoma, 2401 

Chautauqua Avenue, Norman, OK 

73072–7029, telephone (405) 325–1994, 

email mlevine@ou.edu, by October 13, 

2021. After that date, if no additional 

requestors have come forward, transfer 

of control of the human remains and 

associated funerary objects to the Caddo 

Nation of Oklahoma may proceed. 

The Sam Noble Oklahoma Museum of 

Natural History is responsible for 

notifying the Caddo Nation of Oklahoma 

and The Choctaw Nation of Oklahoma 

that this notice has been published. 

Dated: August 25, 2021. 

Melanie O’Brien, 

Manager, National NAGPRA Program. 

[FR Doc. 2021–19691 Filed 9–10–21; 8:45 am] 

BILLING CODE 4312–52–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–892] 

Bulk Manufacturer of Controlled 

Substances Application: Bulk 

Manufacturer of Marihuana: Amethyst 

Exploration, LLC 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: The Drug Enforcement 

Administration (DEA) is providing 

notice of an application it has received 

from an entity applying to be registered 

to manufacture in bulk basic class(es) of 

controlled substances listed in schedule 

I. DEA intends to evaluate this and other 

pending applications according to its 

regulations governing the program of 

growing marihuana for scientific and 

medical research under DEA 

registration. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefor, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before November 12, 2021. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW 8701 

Morrissette Drive, Springfield, Virginia 

22152. To ensure proper handling of 

comments, please reference Docket 

No—DEA–XXX in all correspondence, 

including attachments. 

SUPPLEMENTARY INFORMATION: The 

Controlled Substances Act (CSA) 

prohibits the cultivation and 

distribution of marihuana except by 

persons who are registered under the 

CSA to do so for lawful purposes. In 

accordance with the purposes specified 

in 21 CFR 1301.33(a), DEA is providing 

notice that the entity identified below 

has applied for registration as a bulk 

manufacturer of schedule I controlled 

substances. In response, registered bulk 

manufacturers of the affected basic 

class(es), and applicants therefor, may 

file written comments on or objections 

of the requested registration, as 

provided in this notice. This notice does 

not constitute any evaluation or 

determination of the merits of the 

application submitted. 

The applicant plans to manufacture 

bulk active pharmaceutical ingredients 

(APIs) for product development and 

distribution to DEA registered 

researchers. If the application for 

registration is granted, the registrant 

would not be authorized to conduct 


lotter on DSK11XQN23PROD with NOTICES1
Federal Register / Vol. 86, No. 174 / Monday, September 13, 2021 / Notices 50903 

other activity under this registration 

aside from those coincident activities 

specifically authorized by DEA 

regulations. DEA will evaluate the 

application for registration as a bulk 

manufacturer for compliance with all 

applicable laws, treaties, and 

regulations and to ensure adequate 

safeguards against diversion are in 

place. 

As this applicant has applied to 

become registered as a bulk 

manufacturer of marihuana, the 

application will be evaluated under the 

criteria of 21 U.S.C. 823(a). DEA will 

conduct this evaluation in the manner 

described in the rule published at 85 FR 

82333 on December 18, 2020, and 

reflected in DEA regulations at 21 CFR 

part 1318. 

In accordance with 21 CFR 

1301.33(a), DEA is providing notice that 

on July 1, 2021, Amethyst Exploration, 

LLC., 4210 Jewell Road, Sparta, Georgia 

31087, applied to be registered as a bulk 

manufacturer of the following basic 

class(es) of controlled substances: 

Controlled substance Drug 

code Schedule 

Marihuana Extract ......... 7350 I 

Marihuana ...................... 7360 I 

Tetrahydrocannabinols .. 7370 I 

Brian S. Besser, 

Acting Assistant Administrator. 

[FR Doc. 2021–19629 Filed 9–10–21; 8:45 am] 

BILLING CODE 4410–09–P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–899] 

Bulk Manufacturer of Controlled 

Substances Application: Eli-Elsohly 

Laboratories 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Eli-Elsohly Laboratories has 

applied to be registered as a bulk 

manufacturer of basic class(es) of 

controlled substance(s). Refer to 

Supplementary Information listed below 

for further drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before November 12, 2021. Such 

persons may also file a written request 

for a hearing on the application on or 

before November 12, 2021. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.33(a), this 

is notice that on August 5, 2021, EliElsohly Laboratories, 5 Industrial Park 

Drive, Oxford, Mississippi 38655, 

applied to be registered as an bulk 

manufacturer of the following basic 

class(es) of controlled substance(s): 

Controlled substances Drug 

code Schedule 

Marihuana Extract ......... 7350 I 

Marihuana ...................... 7360 I 

Tetrahydrocannabinols .. 7370 I 

Amphetamine ................ 1100 II 

Methamphetamine ......... 1105 II 

Cocaine ......................... 9041 II 

Codeine ......................... 9050 II 

Dihydrocodeine .............. 9120 II 

Ecgonine ........................ 9180 II 

Thebaine ........................ 9333 II 

The company plans to manufacture 

the listed controlled substances for 

product development and reference 

standards. In reference to drug codes 

7360 (Marihuana) and 7370 

(Tetrahydrocannabinols), the company 

plans to isolate these controlled 

substances from procured 7350 

(Marihuana Extract). In reference to 

drug code 7360, no cultivation activities 

are authorized for this registration. In 

reference to drug code 9333 (Thebaine), 

the company plans to manufacture a 

Thebaine derivative. No other activities 

for these drug codes are authorized for 

this registration. 

Brian S. Bresser, 

Acting Assistant Administrator. 

[FR Doc. 2021–19679 Filed 9–10–21; 8:45 am] 

BILLING CODE P 

DEPARTMENT OF JUSTICE 

Drug Enforcement Administration 

[Docket No. DEA–897] 

Importer of Controlled Substances 

Application: Aurobindo Pharma USA, 

Inc. 

AGENCY: Drug Enforcement 

Administration, Justice. 

ACTION: Notice of application. 

SUMMARY: Aurobindo Pharma USA, Inc. 

has applied to be registered as an 

importer of basic class(es) of controlled 

substance(s). Refer to Supplementary 

Information listed below for further 

drug information. 

DATES: Registered bulk manufacturers of 

the affected basic class(es), and 

applicants therefore, may file written 

comments on or objections to the 

issuance of the proposed registration on 

or before October 13, 2021. Such 

persons may also file a written request 

for a hearing on the application on or 

before October 13, 2021. 

ADDRESSES: Written comments should 

be sent to: Drug Enforcement 

Administration, Attention: DEA Federal 

Register Representative/DPW, 8701 

Morrissette Drive, Springfield, Virginia 

22152. All requests for a hearing must 

be sent to: Drug Enforcement 

Administration, Attn: Administrator, 

8701 Morrissette Drive, Springfield, 

Virginia 22152. All requests for a 

hearing should also be sent to: (1) Drug 

Enforcement Administration, Attn: 

Hearing Clerk/OALJ, 8701 Morrissette 

Drive, Springfield, Virginia 22152; and 

(2) Drug Enforcement Administration, 

Attn: DEA Federal Register 

Representative/DPW, 8701 Morrissette 

Drive, Springfield, Virginia 22152. 

SUPPLEMENTARY INFORMATION: In 

accordance with 21 CFR 1301.34(a), this 

is notice that on July 20, 2021, 

Aurobindo Pharma USA, Inc., 6 

Wheeling Road, Dayton, New Jersey 

08810–1526, applied to be registered as 

an importer of the following basic 

class(es) of controlled substance(s): 

Controlled substance Drug 

code Schedule 

Remifentanil ................... 9739 II 

The company plans to import 

Remifentanil (9739) in bulk form for 

research and development. No other 

activity for this drug code is authorized 

for this registration. 

Approval of permit applications will 

occur only when the registrant’s 

business activity is consistent with what 

is authorized under 21 U.S.C. 952(a)(2). 

Authorization will not extend to the 

import of Food and Drug 

Administration-approved or nonapproved finished dosage forms for 

commercial sale. 

Brian S. Besser, 

Acting Assistant Administrator. 

[FR Doc. 2021–19631 Filed 9–10–21; 8:45 am] 

BILLING CODE P 


lotter on DSK11XQN23PROD with NOTICES1

I I 

I I